King Luther Capital Management Corp lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 71.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 32,000 shares of the company’s stock after selling 80,000 shares during the quarter. King Luther Capital Management Corp’s holdings in Avantor were worth $367,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its stake in Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after buying an additional 1,189 shares during the period. Strategic Wealth Investment Group LLC acquired a new stake in Avantor during the 2nd quarter worth $32,000. Private Trust Co. NA raised its stake in Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after buying an additional 875 shares during the period. Osaic Holdings Inc. raised its stake in Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after purchasing an additional 905 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.
Avantor Stock Performance
AVTR opened at $9.12 on Friday. The business’s 50-day moving average price is $8.02 and its two-hundred day moving average price is $9.76. Avantor, Inc. has a 1 year low of $7.26 and a 1 year high of $15.93. The company has a market capitalization of $6.22 billion, a price-to-earnings ratio of -11.25, a P/E/G ratio of 5.31 and a beta of 0.94. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the company. Barclays dropped their price target on Avantor from $8.50 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, April 14th. Jefferies Financial Group reissued an “underperform” rating and issued a $8.00 price target on shares of Avantor in a research note on Thursday, February 12th. Robert W. Baird set a $11.00 price target on Avantor in a research note on Thursday, February 12th. TD Cowen reissued a “hold” rating on shares of Avantor in a research note on Thursday, February 12th. Finally, Citigroup dropped their price target on Avantor from $11.00 to $9.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Two equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Avantor has an average rating of “Hold” and a consensus target price of $10.82.
Read Our Latest Research Report on AVTR
Insider Activity at Avantor
In related news, Director Simon Dingemans bought 25,000 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were acquired at an average price of $8.14 per share, with a total value of $203,500.00. Following the completion of the transaction, the director owned 25,000 shares in the company, valued at $203,500. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Sanjeev K. Mehra bought 125,000 shares of the stock in a transaction that occurred on Tuesday, March 10th. The stock was bought at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the transaction, the director owned 475,000 shares of the company’s stock, valued at $3,804,750. The trade was a 35.71% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have purchased 160,000 shares of company stock valued at $1,287,950. 0.28% of the stock is owned by insiders.
Avantor Company Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Stories
- Five stocks we like better than Avantor
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
